<SEC-DOCUMENT>0001140361-23-007501.txt : 20230216
<SEC-HEADER>0001140361-23-007501.hdr.sgml : 20230216
<ACCEPTANCE-DATETIME>20230216170159
ACCESSION NUMBER:		0001140361-23-007501
CONFORMED SUBMISSION TYPE:	DFAN14A
PUBLIC DOCUMENT COUNT:		1
FILED AS OF DATE:		20230216
DATE AS OF CHANGE:		20230216

SUBJECT COMPANY:	

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			AMARIN CORP PLC\UK
		CENTRAL INDEX KEY:			0000897448
		STANDARD INDUSTRIAL CLASSIFICATION:	PHARMACEUTICAL PREPARATIONS [2834]
		IRS NUMBER:				000000000
		STATE OF INCORPORATION:			X0
		FISCAL YEAR END:			1231

	FILING VALUES:
		FORM TYPE:		DFAN14A
		SEC ACT:		1934 Act
		SEC FILE NUMBER:	000-21392
		FILM NUMBER:		23639250

	BUSINESS ADDRESS:	
		STREET 1:		SPACES SOUTH DOCKLANDS, BLOCK C
		STREET 2:		77 SIR JOHN ROGERSON'S QUAY
		CITY:			DUBLIN 2
		STATE:			L2
		ZIP:			D02 VK60
		BUSINESS PHONE:		353 1 6699 020

	MAIL ADDRESS:	
		STREET 1:		SPACES SOUTH DOCKLANDS, BLOCK C
		STREET 2:		77 SIR JOHN ROGERSON'S QUAY
		CITY:			DUBLIN 2
		STATE:			L2
		ZIP:			D02 VK60

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	AMARIN PHARMACEUTICALS PLC
		DATE OF NAME CHANGE:	20000201

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	ETHICAL HOLDINGS PLC
		DATE OF NAME CHANGE:	19930322

FILED BY:		

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			Sarissa Capital Management LP
		CENTRAL INDEX KEY:			0001577524
		IRS NUMBER:				900924432
		STATE OF INCORPORATION:			DE
		FISCAL YEAR END:			1231

	FILING VALUES:
		FORM TYPE:		DFAN14A

	BUSINESS ADDRESS:	
		STREET 1:		660 STEAMBOAT ROAD
		CITY:			GREENWICH
		STATE:			CT
		ZIP:			06830
		BUSINESS PHONE:		203-302-2330

	MAIL ADDRESS:	
		STREET 1:		660 STEAMBOAT ROAD
		CITY:			GREENWICH
		STATE:			CT
		ZIP:			06830
</SEC-HEADER>
<DOCUMENT>
<TYPE>DFAN14A
<SEQUENCE>1
<FILENAME>ny20006859x23_dfan14a.htm
<DESCRIPTION>DFAN14A
<TEXT>
<html>
  <head>
    <title></title>
    <!-- Licensed to: Broadridge Financial Solutions, Inc.
         Document created using Broadridge PROfile 23.1.2.5118
         Copyright 1995 - 2023 Broadridge -->
  </head>
<body style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: left; color: #000000;" bgcolor="#ffffff">
  <div>
    <hr style="border: none; border-bottom: 1px solid black; border-top: 4px solid black; height: 10px; color: #ffffff; background-color: #ffffff; text-align: center; margin-left: auto; margin-right: auto;" align="center">
    <div>
      <div style="text-align: center; font-family: 'Times New Roman',Times,serif; font-size: 14pt; font-weight: bold; background-color: rgb(255, 255, 255); color: rgb(0, 0, 0); font-style: normal; font-variant: normal; text-transform: none;">UNITED STATES</div>
      <div style="text-align: center; font-family: 'Times New Roman',Times,serif; font-size: 14pt; font-weight: bold; background-color: rgb(255, 255, 255); color: rgb(0, 0, 0); font-style: normal; font-variant: normal; text-transform: none;">SECURITIES AND
        EXCHANGE COMMISSION</div>
      <div style="text-align: center; font-family: 'Times New Roman',Times,serif; font-size: 12pt; font-weight: bold; background-color: rgb(255, 255, 255); color: rgb(0, 0, 0); font-style: normal; font-variant: normal; text-transform: none;">Washington,
        D.C. 20549</div>
      <div><br>
      </div>
      <div style="text-align: center; font-family: 'Times New Roman',Times,serif; font-size: 18pt; font-weight: bold; background-color: rgb(255, 255, 255); color: rgb(0, 0, 0); font-style: normal; font-variant: normal; text-transform: none;">SCHEDULE 14A</div>
      <div><br>
      </div>
      <div style="text-align: center; font-weight: bold;">Proxy Statement Pursuant to Section 14(a) of the</div>
      <div style="text-align: center; font-weight: bold;">Securities Exchange Act of 1934</div>
      <div><br>
      </div>
      <div>Filed by the Registrant&#8194;&#8201;&#8201;<font style="font-family: 'Segoe UI Symbol', sans-serif;">&#9744;</font></div>
      <div>Filed by a party other than the Registrant&#8194;&#8201;&#8201;<font style="font-family: 'Segoe UI Symbol', sans-serif;">&#9746;</font></div>
      <div><br>
      </div>
      <div>Check the appropriate box:</div>
      <div><font style="font-family: 'Segoe UI Symbol', sans-serif;">&#9744;</font>&#8194;&#8201;&#8201;Preliminary Proxy Statement</div>
      <div><font style="font-family: 'Segoe UI Symbol', sans-serif;">&#9744;</font>&#8194;&#8201;&#8201;Confidential, for Use of the Commission Only (as permitted by Rule 14a-6(e)(2))</div>
      <div><font style="font-family: 'Segoe UI Symbol', sans-serif;">&#9744;</font>&#8194;&#8201;&#8201;Definitive Proxy Statement</div>
      <div><font style="font-family: 'Segoe UI Symbol', sans-serif;">&#9746;</font>&#8194;&#8201;&#8201;Definitive Additional Materials</div>
      <div><font style="font-family: 'Segoe UI Symbol', sans-serif;">&#9744;</font>&#8194;&#8201;&#8201;Soliciting Material under &#167; 240.14a-12</div>
      <div><br>
      </div>
      <div style="text-align: center; font-family: 'Times New Roman',Times,serif; font-size: 24pt; font-weight: bold; background-color: rgb(255, 255, 255); color: rgb(0, 0, 0); font-style: normal; font-variant: normal; text-transform: none;">Amarin
        Corporation plc</div>
      <div style="text-align: center;">
        <hr style="height: 2px; color: #000000; background-color: #000000; margin-left: auto; margin-right: auto; border: none;" align="center" noshade="noshade"></div>
      <div style="text-align: center;">(Name of Registrant as Specified In Its Charter)</div>
      <div><br>
      </div>
      <div style="text-align: center; font-weight: bold;">Sarissa Capital Catapult Fund LLC</div>
      <div style="text-align: center; font-weight: bold;">Sarissa Capital Hawkeye Fund LP</div>
      <div style="text-align: center; font-weight: bold;">ISP Fund LP</div>
      <div style="text-align: center; font-weight: bold;">Sarissa Capital Offshore Master Fund LP</div>
      <div style="text-align: center; font-weight: bold;">Sarissa Capital Master Fund II LP</div>
      <div style="text-align: center; font-weight: bold;">Sarissa Capital Athena Fund Ltd</div>
      <div style="text-align: center; font-weight: bold;">Atom Master Fund LP</div>
      <div style="text-align: center; font-weight: bold;">Sarissa Capital Fund GP LP</div>
      <div style="text-align: center; font-weight: bold;">Sarissa Capital Fund GP LLC</div>
      <div style="text-align: center; font-weight: bold;">Sarissa Capital Offshore Fund GP LLC</div>
      <div style="text-align: center; font-weight: bold;">Sarissa Capital Management GP LLC</div>
      <div style="text-align: center; font-weight: bold;">Sarissa Capital Management LP</div>
      <div style="text-align: center; font-weight: bold;">Alexander J. Denner, Ph.D.</div>
      <div style="text-align: center; font-weight: bold;">Patrice Bonfiglio</div>
      <div style="text-align: center; font-weight: bold;">Paul Cohen, M.D.</div>
      <div style="text-align: center; font-weight: bold;">Mark DiPaolo</div>
      <div style="text-align: center; font-weight: bold;">Keith L. Horn</div>
      <div style="text-align: center; font-weight: bold;">Odysseas Kostas, M.D.</div>
      <div style="text-align: center; font-weight: bold;">Louis Sterling III</div>
      <div style="text-align: center; font-weight: bold;">Diane E. Sullivan</div>
      <div style="text-align: center;">
        <hr style="height: 2px; color: #000000; background-color: #000000; margin-left: auto; margin-right: auto; border: none;" align="center" noshade="noshade"></div>
      <div style="text-align: center;">&#160;(Name of Person(s) Filing Proxy Statement, if other than the Registrant)</div>
      <div><br>
      </div>
      <div>Payment of Filing Fee (Check all boxes that apply):</div>
      <div><font style="font-family: 'Segoe UI Symbol', sans-serif;">&#9746;</font>&#8194;&#8201;&#8201;No fee required</div>
      <div><font style="font-family: 'Segoe UI Symbol', sans-serif;">&#9744;</font>&#8194;&#8201;&#8201;Fee paid previously with preliminary materials</div>
      <div><font style="font-family: 'Segoe UI Symbol', sans-serif;">&#9744;</font>&#8194;&#8201;&#8201;Fee computed on table in exhibit required by Item 25(b) per Exchange Act Rules 14a-6(i)(1) and 0-11</div>
      <div>
        <hr style="border: none; border-bottom: 4px solid black; border-top: 1px solid black; height: 10px; color: #ffffff; background-color: #ffffff; text-align: center; margin-left: auto; margin-right: auto;" align="center"> </div>
      <div style="clear: both; margin-top: 10pt; margin-bottom: 10pt;" class="BRPFPageBreakArea">
        <div style="page-break-after: always;" class="BRPFPageBreak">
          <hr style="margin: 4px 0px; width: 100%; border-width: 0; height: 2px; color: #000000; background-color: #000000; clear: both;" noshade="noshade"></div>
      </div>
      <div><br>
      </div>
      <div>&#160;</div>
      <div><br>
      </div>
      <div>This filing contains a press release issued on February 16, 2023 by Sarissa Capital.</div>
      <div><br>
      </div>
      <div style="clear: both; margin-top: 10pt; margin-bottom: 10pt;" class="BRPFPageBreakArea">
        <div style="page-break-after: always;" class="BRPFPageBreak">
          <hr style="margin: 4px 0px; width: 100%; border-width: 0; height: 2px; color: #000000; background-color: #000000; clear: both;" noshade="noshade"></div>
      </div>
      <div><br>
      </div>
      <div>&#160;
        <div style="text-align: center; font-weight: bold;">SARISSA CAPITAL BLASTS AMARIN&#8217;S REPEATED FALSE STATEMENTS; CLEARLY AMARIN WILL SAY ANYTHING TO KEEP SARISSA OFF THE BOARD</div>
        <div><br>
        </div>
        <div style="text-align: center; font-weight: bold;">Sarissa is Confident that Long Suffering Amarin Shareholders Will Make Up Their Own Minds and Vote &#8220;FOR&#8221; Change at Amarin</div>
        <div><br>
        </div>
        <div style="text-align: justify;">Greenwich, CT, February 16, 2023 &#8211; Sarissa Capital Management LP (&#8220;Sarissa&#8221;) today issued the following statement regarding Amarin Corporation plc (NASDAQ: AMRN):</div>
        <div><br>
        </div>
        <div style="text-align: justify;">Sarissa Capital is outraged but not surprised by Amarin&#8217;s repeated false statements intended to mislead shareholders and switch votes away from Sarissa. Amarin has made these false statements throughout this proxy
          contest, including in its evaluation of the company&#8217;s progress and its own performance, in its characterizations of the board&#8217;s interactions with Sarissa, and, most recently, in the failure of its registrar to be properly instructed. <font style="font-weight: bold;">&#160;<u>Clearly, Amarin is willing to say anything to keep Sarissa, its largest shareholder, off the board.</u></font></div>
        <div><br>
        </div>
        <div style="text-align: justify;">Sarissa is confident that fellow long-suffering shareholders see through the ploys and will vote &#8220;FOR&#8221; necessary change. We shareholders know the truth as we have lived through the nightmarish reality under the
          current regime which resulted in a tremendous destruction of shareholder value and an imperiled European launch. Sarissa urges all shareholders to ignore the false statements and empty promises made by Amarin and make up their own minds.</div>
        <div><br>
        </div>
        <div style="text-align: justify;">Amarin is in dire need of change. Sarissa is Amarin&#8217;s largest shareholder, owning more than 25 million shares. We are long term shareholders and have not sold any shares since acquiring our position. We have an
          exceptional track record of success, including in the cardiovascular space, and we believe our nominees have the experience and qualifications to help unlock Amarin&#8217;s true potential.</div>
        <div><br>
        </div>
        <div style="text-align: justify;">You can vote on the blue proxy card or the white proxy card but if you want to fully support Sarissa, you must make sure that all &#8220;<font style="font-weight: bold;">FOR</font>&#8221; boxes are marked on your proxy card
          (blue or white) before you submit it.</div>
        <div><br>
        </div>
        <div style="text-align: justify;">If you have any questions on how to vote, we recommend that you contact Sarissa&#8217;s proxy solicitor, D.F. King, by calling (800) 331-7024 or emailing <u>AMRN@dfking.com</u>.</div>
        <div><br>
        </div>
        <div style="text-align: justify;">We urge all shareholders to vote &#8220;<font style="font-weight: bold;">FOR</font>&#8221; the Sarissa Nominees and &#8220;<font style="font-weight: bold;">FOR</font>&#8221; the removal of Chairman Per Wold-Olsen on or prior to the
          deadline on Tuesday, February 21, 2023.</div>
        <div><br>
        </div>
        <div>Visit our website at <u>www.freeamarin.com</u><font style="color: #0563C1;">&#160;</font>for helpful information about Sarissa and the need for change at Amarin.</div>
        <div><br>
        </div>
        <div style="text-align: justify; font-weight: bold;">IF YOU ALREADY VOTED &#8220;FOR&#8221; ALL PROPOSALS AND SUBMITTED YOUR BLUE PROXY CARD, THERE IS NOTHING ELSE YOU NEED TO DO TO SUPPORT SARISSA&#8217;S NOMINEES. YOU DO NOT NEED TO VOTE AGAIN.</div>
        <div><br>
        </div>
        <div style="clear: both; margin-top: 10pt; margin-bottom: 10pt;" class="BRPFPageBreakArea">
          <div style="page-break-after: always;" class="BRPFPageBreak">
            <hr style="margin: 4px 0px; width: 100%; border-width: 0; height: 2px; color: #000000; background-color: #000000; clear: both;" noshade="noshade"></div>
        </div>
        <div><br>
        </div>
        <div>&#160;</div>
        <div>The General Meeting of Amarin shareholders is scheduled for February 28, 2023, BUT TO MAKE SURE YOUR VOTE COUNTS, <font style="font-weight: bold;"><u>SUBMIT YOUR VOTE ON OR BEFORE TUESDAY, FEBRUARY 21, 2023</u></font>.</div>
        <div><br>
        </div>
        <div style="font-weight: bold;">Additional Information</div>
        <div><br>
        </div>
        <div>Sarissa Capital Management LP (&#8220;Sarissa Capital&#8221;), together with other participants, filed a definitive proxy statement and an accompanying blue proxy card with the SEC on January 31, 2023, in connection with the solicitation of shareholders
          of Amarin Corporation plc (the &#8220;Company&#8221;) at the general meeting of the Company for the election of Sarissa Capital&#8217;s slate of highly-qualified nominees (the &#8220;General Meeting&#8221;). Shareholders are advised to read the definitive proxy statement and
          other relevant documents related to the General Meeting as they contain important information.</div>
        <div><br>
        </div>
        <div>The definitive proxy statement and other relevant documents are available at no charge on the SEC&#8217;s website at <u>www.sec.gov</u> and at <u>www.freeamarin.com</u>. The definitive proxy statement and other relevant documents are also
          available at no charge by directing a request to Sarissa Capital&#8217;s proxy solicitor, D.F. King &amp; Co., Inc., 48 Wall Street, New York, New York 10005 (Shareholders can call toll-free: (800) 331-7024).</div>
        <div><br>
        </div>
        <table style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; text-align: left; color: #000000;" class="DSPFListTable" id="zab270bc3b8ce459daf70b4f5d8c67242" cellpadding="0" cellspacing="0">

            <tr>
              <td style="width: 72pt; vertical-align: top;">Contact:</td>
              <td style="width: auto; vertical-align: top;">
                <div>Jean Puong<br>
                  Sarissa Capital Management LP<br>
                  <u>info@sarissacap.com</u></div>
              </td>
            </tr>

        </table>
        <div><br>
        </div>
      </div>
      <div><br>
      </div>
      <div><br>
      </div>
      <div>
        <hr style="height: 2px; color: #000000; background-color: #000000; text-align: center; margin-left: auto; margin-right: auto; border: none;" align="center" noshade="noshade"></div>
    </div>
  </div>
</body>
</html>
</TEXT>
</DOCUMENT>
</SEC-DOCUMENT>
